Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer.
dc.contributor.author | Kefeli, Umut | |
dc.contributor.author | Arslan, Cagatay | |
dc.contributor.author | Yildirim, Mahmut Emre | |
dc.contributor.author | Isikdogan, Abdurrahman | |
dc.contributor.author | Karadurmus, Nuri | |
dc.contributor.author | Karabulut, Bulent | |
dc.contributor.author | Cubukcu, Erdem | |
dc.date.accessioned | 2024-02-23T14:31:12Z | |
dc.date.available | 2024-02-23T14:31:12Z | |
dc.date.issued | 2021 | |
dc.department | NEÜ | en_US |
dc.description | Virtual Annual Meeting of the American-Society-of-Clinical-Oncology (ASCO) -- JUN 04-08, 2021 -- ELECTR NETWORK | en_US |
dc.description.abstract | [Abstract Not Availabe] | en_US |
dc.description.sponsorship | Amer Soc Clin Oncol | en_US |
dc.description.sponsorship | Amgen Ilac Tic Ltd Sti, Turkey | en_US |
dc.description.sponsorship | Amgen Ilac Tic Ltd Sti, Turkey | en_US |
dc.identifier.doi | 10.1200/JCO.2021.39.15_suppl.e15561 | |
dc.identifier.issn | 0732-183X | |
dc.identifier.issn | 1527-7755 | |
dc.identifier.issue | 15 | en_US |
dc.identifier.scopusquality | Q1 | en_US |
dc.identifier.uri | https://doi.org/10.1200/JCO.2021.39.15_suppl.e15561 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12452/15087 | |
dc.identifier.volume | 39 | en_US |
dc.identifier.wos | WOS:000708120301226 | en_US |
dc.identifier.wosquality | Q1 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.language.iso | en | en_US |
dc.publisher | Lippincott Williams & Wilkins | en_US |
dc.relation.ispartof | Journal Of Clinical Oncology | en_US |
dc.relation.publicationcategory | Konferans Öğesi - Uluslararası - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | [Keyword Not Available] | en_US |
dc.title | Real-world treatment outcomes from nationwide ONCO-colon Turkey registry in RAS wild-type patients treated with biologics first-line metastatic colorectal cancer. | en_US |
dc.type | Conference Object | en_US |